Cancer
ROCHESTER, Minn. — A genomic test co-developed by Mayo Clinic and SkylineDx can identify whether people with melanoma are at low or high risk for[...]
Latest stories
Cancer
June 23, 2026
Research
June 22, 2026
Neurosciences
June 8, 2026
Sign up to receive email notifications
Explore more topics
Sign up
Mayo Clinic Connect
An online patient support community